Hanyang University Researchers Develop Novel Sensor for Continuous Endoleak Monitoring

The wireless and implantable sensor is robust enough to withstand dynamic process of being crimped into a catheter and deployed inside the vessel Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms-life-threatening bulges in the aorta's abdominal section. However, it carries the risk of recurrence owing to endoleaks after […]

NYSE Content Advisory: Pre-Market Update + Uniphore raises $260 million to boost AI leadership

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on October 22nd — Stocks are down Wednesday morning after the DOW closed at a record yesterday thanks to strong earnings

Leading the AI-Native FMCG Revolution: Justin Floyd to Present RedCloud’s Mission at Major Wall Street Investor Events

(NASDAQ:RCT), LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) — RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the technology company behind the RedAI trading platform for businesses across Fast Moving Consumer Goods (“FMCG”) supply chains, today announced that CEO Justin Floyd will participate in two prominent U.S. investor conferences in November, as RedCloud continues to

Leading the AI-Native FMCG Revolution: Justin Floyd to Present RedCloud’s Mission at Major Wall Street Investor Events

Leading the AI-Native FMCG Revolution: Justin Floyd to Present RedCloud's Mission at Major Wall Street Investor Events Showcasing an AI infrastructure Vision for Addressing $2 Trillion FMCG Inventory Challenge GlobeNewswire October 22, 2025 LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) — RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the technology company behind the RedAI

Author Careshmeh French-Dean Debuts Made for Me: A Memoir of Grief, Recovery, and Enduring Strength

Author and speaker Careshmeh French-Dean will release her bold and deeply personal memoir titled Made for Me on October 25th, 2025. https://mma.prnewswire.com/media/2802657/Careshmeh_Dean_Author_Careshmeh_French_Dean.jpg In Made for Me, Dean guides readers through a powerful journey of grief, recovery and rebirth. Rooted in the raw truths of loss and the untapped strength within, the book weaves together her

Award-Winning Book “The One Week Writing Workshop” to Become Online Training Course

70+ how-to videos on the fiction writing process based on the bestselling book by author Karin Adams. Author In Your Corner announces the development of an online video course based onThe One Week Writing Workshop: 7 Days to Spark, Boost or Revive Your Novel. Featuring the book's author Karin Adams as the instructor, the course

Astrada to Bring Real-Time Expense Reporting into Workday

Astrada's unified API enables real-time data sharing and spend visibility for Workday customers Astrada, the unified API for transaction data, today announced a collaboration with Workday to bring real-time transaction credit card feeds into the Workday platform. Astrada's live transaction connectivity will combine with Workday's AI-powered platform to help organizations gain more accurate, immediate visibility

Get Your Sweet On — The Great Candy Run Returns for Its 22nd Year

November 9, 2025 • Washington Park • Benefiting the Fetal Health Foundation It's time to lace up your running shoes and grab your candy bag! The 22nd Annual Great Candy Run returns to Denver's Washington Park on Sunday, November 9, 2025, offering a fun, family-focused 5K run/walk with sweetness at every turn. This beloved event

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

(NasdaqGM:FULC), CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its third quarter 2025 financial results will be released on Wednesday, October 29, 2025, before the

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET GlobeNewswire October 22, 2025 CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of

Scroll to Top